- Role of Noninvasive Diagnostic Imaging in Cardiac Amyloidosis: A Review
-
Oda S, Utsunomiya D, Nakaura T, Takashio S, Izumiya Y, Tsujita K, Ueda M, Yamashita T, Ando Y, Kawano Y, Okuno Y, Hata H, Yamashita Y
- KMID: 2524868
- Cardiovasc Imaging Asia.
- 2018 Apr;2(2):97-106.
- doi: 10.22468/cvia.2018.00059
Historically, cardiac amyloidosis (CA) has been considered a rare disease; however, recent research has revealed a considerable number of hidden CA cases in patients with heart failure, especially in those... -
- CITED
-
- Close
- SHARE
-
- Close
- HFA-PEFF scores: prognostic value in heart failure with preserved left ventricular ejection fraction
-
Egashira K, Sueta D, Komorita T, Yamamoto E, Usuku H, Tokitsu T, Fujisue K, Nishihara T, Oike F, Takae M, Hanatani S, Takashio S, Ito M, Yamanaga K, Araki S, Soejima H, Kaikita K, Matsushita K, Tsujita K
- KMID: 2524245
- Korean J Intern Med.
- 2022 Jan;37(1):96-108.
- doi: 10.3904/kjim.2021.272
Background/Aims: The Heart Failure Association (HFA)-PEFF score is recognized as a simple method to diagnose heart failure (HF) with preserved ejection fraction (HFpEF). This study aimed to evaluate the relationship... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of the Effects of Ezetimibe-Statin Combination Therapy on Major Adverse Cardiovascular Events in Patients with and without Diabetes: A Meta-Analysis
-
Hong N, Lee YH, Tsujita K, Gonzalez J, Kramer CM, Kovarnik T, Kouvelos G, Suzuki H, Han K, Lee CJ, Park SH, Lee BW, Cha BS, Kang ES
- KMID: 2420490
- Endocrinol Metab.
- 2018 Jun;33(2):219-227.
- doi: 10.3803/EnM.2018.33.2.219
BACKGROUND: Ezetimibe-statin combination therapy has been found to reduce low density lipoprotein cholesterol levels and the risk of major adverse cardiovascular events (MACEs) in large trials. We sought to examine... -
- CITED
-
- Close
- SHARE
-
- Close
